Newsroom

DUBLIN--(BUSINESS WIRE)--The "Pharmaceutical Regulatory Affairs in Asia Training Course (Mar 24th - Mar 26th, 2026)" training has been added to ResearchAndMarkets.com's offering. The pharmaceutical market in Asia is growing at a rapid pace and presents both opportunities and challenges to those wishing to work in the region. Rather than a single market, Asia is a collection of different markets, each with their own regulatory processes, although harmonisation exists within the ASEAN countries....

LAKE FOREST, Ill.--(BUSINESS WIRE)--Packaging Corporation of America (NYSE: PKG) will hold a conference call on Wednesday, January 28, 2026, at 9:00 a.m. Eastern Time to discuss fourth quarter and full year 2025 results. The conference call leader will be Mark Kowlzan. Fourth quarter and full year earnings results will be released after the market closes on Tuesday, January 27, 2026. To access the conference call, you may pre-register for the conference by navigating to https://dpregister.com/s...

DENVER--(BUSINESS WIRE)--Modivcare Inc. (the “Company” or “Modivcare”) (OTCMKTS: MODVQ), a technology-enabled healthcare services company providing a platform of integrated supportive care solutions focused on improving health outcomes, today announced the completion of its financial restructuring process and emergence from Chapter 11 protection. Modivcare achieved the objectives it set for this process, including meaningfully reducing funded debt by $1.1 billion—more than 85% of prior funded d...

PLANO, Texas--(BUSINESS WIRE)--Secretome Therapeutics, a clinical-stage biotechnology company developing novel cellular and cell-based therapies derived from neonatal cardiac progenitor cells (nCPCs), today announced that it will present at the 2026 J.P. Morgan Healthcare Conference, taking place January 12–15, 2026, in San Francisco, California. Secretome Therapeutics’ presentation is scheduled for Thursday, January 15, 2026, from 9:00 AM to 9:25 AM (PT). During the presentation, the company w...

LONDON--(BUSINESS WIRE)--  Re: SNB FUNDING LIMITED AUD 20,000,000.00 MATURING: 27-Jun-2033 ISIN: XS2642669043 PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 29-Dec-2025 TO 27-Mar-2026 HAS BEEN FIXED AT 5.49 PCT DAY BASIS: ACTUAL/365(FIX) INTEREST PAYABLE VALUE 27-Mar-2026 WILL AMOUNT TO: AUD 2,647.23 PER AUD 200,000.00 DENOMINATION  ...

DUBLIN--(BUSINESS WIRE)--The "Introduction to Veterinary Pharmacovigilance Training Course (Mar 9th - Mar 10th, 2026)" training has been added to ResearchAndMarkets.com's offering. This two-day event has been designed to provide an essential overview of veterinary pharmacovigilance and will offer practical guidance and basic training for all those working in drug safety in the EU. Our experienced trainer will clarify roles and responsibilities, explain commonly used terminology and take partici...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust SMID Rising Dividend Achievers UCITS ETF 24.12.2025 SDVI.LN IE000YVOQ2A3 40,361.00 USD 1,076,517.63 26.672  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust SMID Rising Dividend Achievers UCITS ETF 24.12.2025 SDVY.LN IE0001R850E1 10,754,007.00 USD 251,858,334.53 23.420  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Growth Strength UCITS ETF 24.12.2025 FTGS.LN IE000YZLMXT9 25,002.00 USD 561,854.21 22.472  ...

LONDON--(BUSINESS WIRE)--  Re: First Abu Dhabi Bank P.J.S.C. AUD 35,000,000.00 MATURING: 29-Jun-2026 ISIN: XS2358731177 PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 29-Dec-2025 TO 30-Mar-2026 HAS BEEN FIXED AT 4.48 PCT DAY BASIS: ACTUAL/365(PROP) INTEREST PAYABLE VALUE 30-Mar-2026 WILL AMOUNT TO: AUD 11,169.32 PER AUD 1,000,000.00 DENOMINATION  ...